Global Topical Antibiotics Market Research Report 2021

Topical antibiotics pharmaceuticals are used to treat infections of the skin and are commonly applied as creams and ointments. Antibiotics are agents that destroy or inhibit the growth of microorganisms, which are sensitive to them. Few topical antibiotics are sold without prescription from physicians and are available in several forms such as ointments, creams, sprays and powders. Topical antibiotics prevents infection caused by bacteria which get into minor scrapes, burns, and cuts. Treating minor injuries with antibiotics allows faster healing. If the injuries are left untreated, the bacteria will multiply and create redness, itching, swelling, oozing, and causing pain. Untreated infections can ultimately spread and become more serious. Soft tissue and dermal bacterial infections are one of the most commonly occurring conditions amongst people accounting for over 25 million visits to physicians every year. Most of these infections are minor and chronic in nature causing irritation and can be treated as outpatient procedures. Topical antibiotics are a large generic group of pharmaceutical products catering to the treatment of these commonly occurring conditions. A large variety of bacteria such as Staph aureus, Streptococcus viridians, Enterococcus faecalis and Staph pyogenes are responsible for these infections.

The global Topical Antibiotics market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Topical Antibiotics volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Topical Antibiotics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Topical Antibiotics Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Ointments
Creams
Powder
Gels
Others

Segment by Application
Skin Infection
Eye Infection
Bromhidrosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novartis AG
GlaxoSmithKline plc
Perrigo Company plc
Pfizer, Inc
Almirall, S.A.
Bausch Health Companies, Inc
Medimetriks Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited.

Frequently Asked Questions